Re-Engineering Healthcare To Eliminate Preventable Deaths


Joe Kiani is a busy man.  As the founder, Chairman, and CEO of Masimo Corporation, a global medical device manufacturer, Kiani has been a leader in patient safety and healthcare innovation for...

Masimo iSpO2 hands-on: track your pulse and blood oxygen with your iPhone

Masimo iSpO2 handson track your pulse and blood oxygen with your iPhone

Pulse Oximeters are an essential hospital tool and serious athletes rely on them to track the efficiency with which they pump oxygen into their blood stream. Masimo's new iSpO2 puts these rather important health metrics within reach of the consumer by tying the sensor to your favorite iOS device through an app. The device, available now for $249 through Amazon, feeds your blood oxygen level, pulse rate and perfusion index (the rate of blood flow to your finger) to an easy-to-read app. In addition to just large raw numbers, the app also offers a history-tracking graph, along with a confidence rating for the reading -- so you know when the data coming in and out is reliable. The device itself is primarily light soft-touch plastic and rubber, with a slightly glossier clip that goes over your finger. At the opposite end of the device is the standard 30-pin connector for plugging into your old-school iOS devices. Though, frequent upgraders will be happy to hear that Lightning adapters work perfectly fine with the iSpO2.

Primarily the monitor is aimed at athletes and aviators who tend to find themselves in unpressurized aircraft. Beyond that, there could be general health applications for those with chronic circulation issues or other blood-related health problems. The sensor even works when under stress from constant movement -- an important feature since Masimo expects runners and hikers are expected actually wear the device when active. For a bit more, check out the gallery below and the video after the break.

Continue reading Masimo iSpO2 hands-on: track your pulse and blood oxygen with your iPhone

Filed under: ,

Comments